Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL, Christiansen C, Rowell L, Mairon N, Bonvoisin B, Drezner MK, Emkey R, Felsenberg D, Cooper C, Delmas PD, Miller PD. Reginster JY, et al. Among authors: christiansen c. Ann Rheum Dis. 2006 May;65(5):654-61. doi: 10.1136/ard.2005.044958. Epub 2005 Dec 8. Ann Rheum Dis. 2006. PMID: 16339289 Free PMC article. Clinical Trial.
Oral weekly ibandronate prevents bone loss in postmenopausal women.
Tankó LB, Felsenberg D, Czerwiński E, Burdeska A, Jonkanski I, Hughes C, Christiansen C; Oral Ibandronate Group. Tankó LB, et al. Among authors: christiansen c. J Intern Med. 2003 Aug;254(2):159-67. doi: 10.1046/j.1365-2796.2003.01174.x. J Intern Med. 2003. PMID: 12859697 Free article. Clinical Trial.
1,618 results